These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974 [TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720 [TBL] [Abstract][Full Text] [Related]
5. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Deb B; Bradford K; Pearl RG Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832 [TBL] [Abstract][Full Text] [Related]
6. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH). Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113 [TBL] [Abstract][Full Text] [Related]
7. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Morris K; Beghetti M; Petros A; Adatia I; Bohn D Crit Care Med; 2000 Aug; 28(8):2974-8. PubMed ID: 10966281 [TBL] [Abstract][Full Text] [Related]
8. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. Atz AM; Adatia I; Lock JE; Wessel DL J Am Coll Cardiol; 1999 Mar; 33(3):813-9. PubMed ID: 10080486 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure. Cai J; Su Z; Shi Z; Zhou Y; Xu Z; Liu J; Chen L; Xu Z; Yu X; Ding W; Yang Y Artif Organs; 2008 Nov; 32(11):864-9. PubMed ID: 18959679 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741 [TBL] [Abstract][Full Text] [Related]
11. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227 [TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. Krasuski RA; Warner JJ; Wang A; Harrison JK; Tapson VF; Bashore TM J Am Coll Cardiol; 2000 Dec; 36(7):2204-11. PubMed ID: 11127462 [TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
14. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics. Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829 [TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310 [TBL] [Abstract][Full Text] [Related]
17. Response to inhaled nitric oxide in patients with acute right heart syndrome. Bhorade S; Christenson J; O'connor M; Lavoie A; Pohlman A; Hall JB Am J Respir Crit Care Med; 1999 Feb; 159(2):571-9. PubMed ID: 9927375 [TBL] [Abstract][Full Text] [Related]
18. Sustained pulmonary vasodilation after inhaled nitric oxide for hypoxic pulmonary hypertension in swine. Emil S; Kanno S; Berkeland J; Kosi M; Atkinson J J Pediatr Surg; 1996 Mar; 31(3):389-93. PubMed ID: 8708909 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension. Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861 [TBL] [Abstract][Full Text] [Related]